ECO Animal Health Regulatory Approval
March 05 2019 - 2:00AM
UK Regulatory
TIDMEAH
ECO Animal Health Group plc
(AIM: EAH)
ECO RECEIVES MARKETING AUTHORISATION FOR AIVLOSIN® FOR CHICKENS
LAYING EGGS FOR HUMAN CONSUMPTIONIN INDIA
ECO Animal Health Group plc (the "Group") is pleased to announce
that its subsidiary ECO Animal Health Limited (ECO) has received a
marketing authorisation from the Central Drugs Standard Control
Organisation, Ministry of Health & Family Welfare of the
Government of India for the use of Aivlosin® 625 mg/g water soluble
granules in chickens laying eggs for human consumption.
This approval allows ECO to start selling Aivlosin® in India for
the medication of drinking water for the treatment of infections
caused by Mycoplasma in poultry laying eggs for human consumption,
with a zero day drug withdrawal period for eggs.
Aivlosin®, ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
Peter Lawrence, Non-Executive Chairman of ECO Animal Health
Group plc, commented "India is ranked second with just over 5 per
cent of the world's laying birds and although the market is
somewhat fragmented, we expect this to change in the future. This
latest approval demonstrates ECO's continued progress in rolling
out this indication for commercial layers".
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190304005702/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
March 05, 2019 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024
